Peptides DB
Research-centric peptide and protocol reference hub
Study 8 of 13Lypressin literatureThe Journal of physiology · ObservationalHigh-impact journal1986

Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin.

The study found that 66% of rat paraventricular nucleus neurons responded excitably to vasopressin, indicating a significant effect of this peptide on neuronal activity.

Read at The Journal of physiologyAdd to compare

Where it sits

this study against the rest of the lypressin corpus
1
Preclinical
8
Observational · this one
0
Open-label
1
Randomised
3
Reviews

Summary and findings

The study measured the excitatory and inhibitory responses of neurons in the rat paraventricular nucleus to arginine-vasopressin (AVP) and oxytocin (OXT) at a concentration of 10(-7) M. It was found that 66% of tested cells responded to AVP with excitatory responses, while 57% responded to OXT. The research provides insights into the firing patterns and responses of these neurons to the peptides.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
66% of ninety-seven p.v.n. cells showed excitatory responses to AVP.1986

Abstract

The authors’ words, as The Journal of physiology supplied them

Extracellular recordings were made from ninety-seven spontaneously firing cells in the paraventricular nucleus (p.v.n.) of the rat hypothalamic slice preparation. The spontaneously firing cells tested fired at 0.1-8 spikes/s but the majority showed a slow irregular firing pattern. The average firing rate of all ninety-seven cells was 2.2 +/- 0.2 spikes/s (mean +/- S.E. of mean). Six cells showed a phasic firing pattern. Following bath application of arginine-vasopressin (AVP) 10(-7) M, sixty-four (66%) of ninety-seven p.v.n. cells showed excitatory responses and three (3%) cells inhibitory responses. Bath application of oxytocin (OXT) 10(-7) M excited thirty-nine (57%) of sixty-eight p.v.n. cells and inhibited two (3%) cells. Individual p.v.n. cells responded to application of both AVP and OXT, but the magnitude and threshold of the responses varied from cell to cell. Of the sixty-six cells tested with both peptides at 10(-7) M, sixteen showed similar responses to both and fifteen showed no response to either: twenty cells showed a greater response to AVP and fifteen a greater response to OXT. Of six phasic firing cells, two showed excitatory responses to AVP and all four cells tested did not show any response to OXT. The dose-dependence of the response to AVP and OXT was tested in six p.v.n. cells. There was a direct relationship between peptide concentration and increased firing rate. The threshold concentration of the peptides ranged from 10(-8) to 10(-10) M. The cells responsive to the peptides were not located in particular areas of the p.v.n. but were diffusely distributed throughout the nucleus. After blocking synaptic transmission with a low Ca2+ and high Mg2+ medium, all tested cells (AVP, n = 15; OXT, n = 14) which had responded to applications of AVP or OXT in normal medium still showed responses to the peptides, although the effect was less marked in half the cells. However, in the absence of synaptic transmission two cells showed unimpaired responses to one of the peptides but greatly depressed responses to the other. The V1-receptor antagonist [1-(beta-mercapto-, beta-cyclopentamethylenepropionic acid)], 8-D-arginine-vasopressin (d(CH2)5DAVP) or V1/V2-receptor antagonist [1-(beta-mercapto-, beta-cyclopentamethylenepropionic acid), 2-D-tyrosine,4-valine]arginine-vasopressin (d(CH2)5D-TyrVAVP) completely or partly blocked the AVP-induced responses, while the V2-receptor agonist 1-deamino-8-D-arginine-vasopressin (dDAVP) did not influence the spontaneous discharges of the cells.(ABSTRACT TRUNCATED AT 400 WORDS)

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Lypressin corpus

BNursing intensity trajectory patterns and clinical outcomes in intensive care units: a latent class analysis.International journal of nursing studies advances · 2026 · n=7334 · Rapid Improvement associated with 74% lower mortality odds (OR = 0.26, 95% CI: 0.18-0.36, p < 0.001).HumanDBeyond the pump: integrating the heart's endocrine function into early medical education.Medical education online · 2026reviewCIntegrated Phytochemical Characterisation, Pharmacological Evaluation and Computational Investigation of &lt;i&gt;Acampe papillosa&lt;/i&gt; Stem Extract.Analytical science advances · 2026 · Rectal temperature reduced to 98.04 ± 0.05°F at 21 h post-treatment.AnimalDResearch progress on the role and mechanism of STIM and Orai protein-mediated store-operated calcium entry in cardiovascular diseases.Channels (Austin, Tex.) · 2026reviewCEffects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin.General physiology and biophysics · 1984 · Stimulation by dDAVP was delayed by about 30 min compared to LVP (P < 0.01).AnimalBPoor sleep quality and its association patterns with eating disorders, body composition and physical activity among university students in Douala-Cameroon.IBRO neuroscience reports · 2026 · n=522 · 73.7% prevalence of poor sleep quality among students.Human